Searched for
NICOTINELL
Dr Reddy’s Q1 Results Preview: PAT may grow up to 15% YoY, revenue to surge up to 19%Dr Reddy’s Q1FY26 earnings are expected to show steady revenue growth and resilient domestic demand, with mixed profit estimates ranging fr...- Dr Reddy's Labs Q2 Results: Profit falls 15% YoY to Rs 1,255 crore, revenue up 17%Dr Reddy's Labs Q2 Results: Healthcare major Dr Reddy's on Tuesday reported 15% drop in its consolidated net profit at Rs 1255 crore in the...
- Dr Reddy's completes acquisition of Haleon's NRT portfolioDr Reddy's Laboratories has acquired Haleon's global Nicotine Replacement Therapy (NRT) portfolio, excluding the US, for GBP 458 million. T...
- Dr Reddy’s Laboratories board announces 1:5 stock splitAdditionally the company has also announced that each American Depositary Share (ADS) will still represent 1 equity share. As a result, the...
- Dr. Reddy's Lab Q1 Results: Profit down 1% to Rs 1,392 crore but revenue jumps 14%Dr. Reddy's Lab Q1 Results: While announcing the quarterly numbers, the company's board also approved split of equity shares in the ratio o...
- Stocks in news: Inox Green, Titagarh Rail, India Cements, Dr Reddy's, Bharti AirtelJSW Energy arm JSW Neo Energy signed power purchase agreements (PPAs) for wind and solar projects with a cumulative capacity of 1,325 MW.
- Dr Reddy's to buy nicotine replacement brands from UK-based Haleon for $632 millionThe portfolio to be acquired consists of Nicotinell, a global leader in the NRT category with an extensive footprint in over 30 countries s...
- Novartis revamps pharma world with mega-deals with GSK, Eli LillyThe Swiss drugmaker said it would divest its vaccines business, excluding flu, to GSK for $7.1 million plus royalties.
Load More